CPHI Milan 2
CPHI Milan newsletter
PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical

WFS Gains IATA CEIV Pharma Certification in Brussels

Brussels has become the first of Worldwide Flight Services’ (WFS) European cargo stations to achieve IATA CEIV Pharma certification.
The world’s largest cargo handler is in the process of certification for either Good Distribution Practice (GDP) or IATA CEIV Pharma at major locations across its network, which also includes building new facilities at stations including Paris, Milan and Copenhagen.
Pharma volumes handled by WFS in Brussels rose by some 170% in 2016 and will soar to a new high in 2017. Volumes in the first 10 months of the year have already exceeded three million kilos.
Marc Claesen, Regional Vice President of WFS in Belgium, said: “We are proud to be the first WFS station in Europe with CEIV accreditation and to be supporting our customers and the efforts of Brussels Airport to create the world’s first CEIV-certified airport community.”
To manage its customers’ growing pharma volumes, WFS has installed two new dedicated pharma cells in its main warehouse in Brussels to help maintain the integrity of pharma products within 15-25°C and 2-8°C temperature-controlled environments. As part of its successful CEIV certification programme, it has also adopted specific pharma handling procedures and provided training for its staff working in the upgraded facility.
John Batten, WFS’ EVP Cargo Europe Middle East Africa & Asia, added: “We are continuing to listen to the needs of our airline customers and to support them with new and enhanced facilities where we see opportunities that offer growth potential for them and for WFS. Delivering further improvements to our pharma handling services at major stations is one of our key areas of focus and this will continue in 2018 with investments and GDP or CEIV certifications at more of our locations with high pharma volumes.”

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026